Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Gastric carcinoma with a lymphoid stroma].
Oliva E, Alejo M, Peiró G, Guix M. Oliva E, et al. Among authors: guix m. Rev Esp Enferm Dig. 1991 Mar;79(3):205-7. Rev Esp Enferm Dig. 1991. PMID: 1645984 Spanish.
Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients.
Mena M, Taberna M, Tous S, Marquez S, Clavero O, Quiros B, Lloveras B, Alejo M, Leon X, Quer M, Bagué S, Mesia R, Nogués J, Gomà M, Aguila A, Bonfill T, Blazquez C, Guix M, Hijano R, Torres M, Holzinger D, Pawlita M, Pavon MA, Bravo IG, de Sanjosé S, Bosch FX, Alemany L. Mena M, et al. Among authors: guix m. Oral Oncol. 2018 Mar;78:137-144. doi: 10.1016/j.oraloncology.2018.01.010. Epub 2018 Feb 20. Oral Oncol. 2018. PMID: 29496041 Free article.
Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe.
Mena M, Frias-Gomez J, Taberna M, Quirós B, Marquez S, Clavero O, Baena A, Lloveras B, Alejo M, León X, García J, Mesía R, Bermejo O, Bonfill T, Aguila A, Guix M, Hijano R, Pavón MA, Torres M, Tous S, Clèries R, Alemany L. Mena M, et al. Among authors: guix m. Sci Rep. 2020 Aug 6;10(1):13219. doi: 10.1038/s41598-020-70118-7. Sci Rep. 2020. PMID: 32764593 Free PMC article.
New agents for bladder cancer.
Bellmunt J, Guix M. Bellmunt J, et al. Among authors: guix m. Ann Oncol. 2010 Oct;21 Suppl 7:vii56-8. doi: 10.1093/annonc/mdq367. Ann Oncol. 2010. PMID: 20943643 Free article. Review.
Prognostic and Predictive Factors for Renal Cell Carcinoma.
Suárez C, Campayo M, Bastús R, Castillo S, Etxanitz O, Guix M, Sala N, Gallardo E. Suárez C, et al. Among authors: guix m. Target Oncol. 2018 Jun;13(3):309-331. doi: 10.1007/s11523-018-0557-2. Target Oncol. 2018. PMID: 29569164 Review.
Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era.
Bellmunt J, Esteban E, Del Muro XG, Sepúlveda JM, Maroto P, Gallardo E, Del Alba AG, Etxaniz O, Guix M, Larriba JLG, Arranz JA, Redrado M, Calvo A. Bellmunt J, et al. Among authors: guix m. Eur Urol Oncol. 2021 Jun;4(3):502-505. doi: 10.1016/j.euo.2019.07.014. Epub 2019 Aug 30. Eur Urol Oncol. 2021. PMID: 31477526 Clinical Trial.
87 results